Head-to-head · WeighScore
Peter MD vs RxSpan MD
The verdict
RxSpan MD takes it — 86.8/100 to 78.1/100.
RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A physician-led telehealth under board-certified founder Dr. John Diaz with a broad GLP-1 menu — compounded semaglutide and tirzepatide by injection or oral capsule, plus a brand-name lane and microdosing — on transparent all-inclusive pricing to all 50 states.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Peter MD | RxSpan MD |
|---|---|---|
| WeighScore | 78.1/100 | 86.8/100 |
| Grade | C+ | B |
| Scorecard rank | #37 | #4 |
| Semaglutide | $139-149/mo (compounded w/ B12) | From $194/mo |
| Tirzepatide | $149 first month, then $249/mo (quarterly) | $329/mo |
| Coverage | Most states — exclusions vary by treatment | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #37 · C+
Strengths
- Broad multi-category catalog on one account — TRT, GLP-1, ED, non-GLP-1 weight loss, men's hair loss and NAD+
- Physician-prescribed, nationwide telehealth operating since 2021
- Genuinely cheap TRT entry — $79/mo testosterone cypionate on a 12-month plan
- Low tirzepatide first-month rate ($149) at a real 60mg dose
Where it loses points
- Tirzepatide steps up from $149 the first month to $249/mo, billed quarterly
- Semaglutide's own pricing is hard to compare at a glance — $149/mo for first-time patients vs $139/mo for returning ones, with very different total costs ($447 vs $834) over similar supply windows
- The affiliate program discloses a wider list of state exclusions (varying by treatment, touching AL, AR, CA, ID, IA, KY, LA, MA, MI, NC, SC and TX) than any single customer-facing pricing page states
- TRT and tirzepatide both require locking into quarterly or 12-month billing to get the advertised rate
- No named medical director or lab/monitoring detail published; customer reviews are mixed
Graded #4 · B
Strengths
- Available in all 50 states
- Transparent, all-inclusive published pricing — consult, medication, supplies, shipping and support, cancel anytime, from ~$194/mo compounded semaglutide on an annual plan
- Both injectable and a real oral (capsule) route, plus compounded and an advertised brand-name lane
- Physician-led by a named, board-certified founder (Dr. John Diaz) with 24/7 messaging and coaching
Where it loses points
- Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
- Published pricing is for the compounded line — brand-name pricing isn’t itemized
- A prescription isn’t guaranteed — a provider reviews eligibility after checkout
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 501 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.